KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $65.50 $80.00 Friday, 26th Apr 2024 AXSM stock ended at $71.71. This is 0.266% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.92% from a day low at $69.70 to a day high of $72.43.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Apr 28, 2023 $71.17 $71.68 $69.66 $71.53 381 839
Apr 27, 2023 $70.25 $71.58 $69.80 $71.16 367 107
Apr 26, 2023 $71.00 $71.67 $67.50 $70.11 809 013
Apr 25, 2023 $73.45 $74.10 $70.79 $71.23 500 030
Apr 24, 2023 $72.81 $73.59 $70.77 $73.32 523 271
Apr 21, 2023 $71.64 $76.35 $71.64 $72.92 1 073 440
Apr 20, 2023 $71.57 $71.99 $69.91 $71.29 662 934
Apr 19, 2023 $72.85 $72.85 $70.99 $72.15 525 840
Apr 18, 2023 $70.70 $72.92 $69.91 $72.85 917 939
Apr 17, 2023 $68.99 $71.90 $68.99 $70.46 1 440 460
Apr 14, 2023 $64.71 $68.69 $64.33 $68.50 1 255 658
Apr 13, 2023 $63.95 $66.47 $63.66 $65.05 619 193
Apr 12, 2023 $61.65 $64.78 $61.14 $63.64 1 159 172
Apr 11, 2023 $61.30 $62.56 $59.98 $61.03 760 052
Apr 10, 2023 $59.58 $61.66 $56.75 $61.59 817 410
Apr 06, 2023 $58.84 $59.86 $57.30 $59.75 773 822
Apr 05, 2023 $59.58 $60.31 $57.47 $58.41 908 459
Apr 04, 2023 $62.77 $62.80 $59.52 $59.93 851 212
Apr 03, 2023 $61.73 $63.35 $61.57 $62.98 512 903
Mar 31, 2023 $61.31 $62.61 $60.37 $61.68 664 648
Mar 30, 2023 $62.97 $63.00 $58.69 $60.55 1 112 906
Mar 29, 2023 $62.50 $62.89 $61.01 $62.44 463 374
Mar 28, 2023 $64.07 $64.32 $60.74 $61.51 727 700
Mar 27, 2023 $62.18 $64.15 $61.80 $63.92 503 857
Mar 24, 2023 $61.40 $62.58 $59.74 $61.96 698 914
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT